Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 28, 2017

Study Completion Date

May 31, 2017

Conditions
Healthy MenMale Contraception
Interventions
DRUG

Dimethandrolone Undecanoate

Daily doses of 100, 200 and 400mg of dimethandrolone undecanoate

DRUG

Placebo

Placebo with capsules that look like the DMAU capsules but with no active ingredients

Trial Locations (2)

90502

Los Angeles Biomedical Research Institute, Torrance

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

University of Washington

OTHER

lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

NCT01382069 - Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men | Biotech Hunter | Biotech Hunter